DeutschNewstral
Article
jdsupra.com on 2022-11-28 21:49
2021 PMPRB Annual Report
Related news
- PMPRB publishes annual Meds Pipeline Monitor reportjdsupra.com
- PMPRB releases 2020 Annual Report and April 2022 NEWSletterjdsupra.com
- PMPRB releases 2022 Annual Report and March 2024 NEWSletterjdsupra.com
- PMPRB releases CompassRx Annual Public Drug Plan Expenditure Report (2021/22)jdsupra.com
- CFIUS 2021 Annual Report: Considerations for Businessesjdsupra.com
- PMPRB releases three new NPDUIS reportsjdsupra.com
- Key Takeaways from the CFIUS Annual Report for 2021jdsupra.com
- Amendments to PMPRB Regulations will now be in force July 1, 2021jdsupra.com
- Amendments to PMPRB Regulations will now be in force January 1, 2021jdsupra.com
- Canadian Institute for Health Information (CIHI) and Patented Medicine Prices Review Board (PMPRB) report upward trend of high-cost drugsjdsupra.com
- PMPRB adopts Amended Interim Guidance pending release of new guidelinesjdsupra.com
- Few significant changes made in final PMPRB Guidelinesjdsupra.com
- Innovators challenge final PMPRB Guidelines in new Federal Court applicationjdsupra.com
- PMPRB proposes to modify Guidelines definition of "gap medicine" to include medicines sold by July 1, 2021jdsupra.com
- PMPRB finds ultra-rare drug PROCYSBI is excessively pricedjdsupra.com
- PMPRB releases analytic study of Canadian oncology marketjdsupra.com
- CFIUS Filing Considerations in Light of E.O. 14083 and CFIUS's 2021 Annual Reportjdsupra.com
- OSC Sets Out Interpretative Guidance in its Corporate Finance Branch Annual Report for 2021jdsupra.com
Highlights from the 2021 annual report from the Auditor General of Ontariothestar.com- Committee on Foreign Investment in the United States: 2021 Annual Report to Congressjdsupra.com